Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced a significant venture investment in Patho Care, LLC, a leader in the “lab on a chip” non-invasive point of care diagnostic tests. Patho Care’s revolutionary Raman spectroscopy-based testing platform is underpinned by 17 patents. The transaction, valued at $150.15 million, was structured as a acquisition and recapitalization using newly issued common stock and cash through a newly formed entity, PathoCare Holdings, Inc., to streamline the investment and operational framework.
Read the full article: Hamershlag Private Capital Management Limited Makes $150M Venture Structured Investment in Patho Care, LLC via PathoCare Holdings, Inc. //
Source: https://www.businesswire.com/news/home/20241231660893/en/Hamershlag-Private-Capital-Management-Limited-Makes-150-Million-Venture-Structured-Investment-in-Patho-Care-LLC-via-PathoCare-Holdings-Inc.